| Consensus: guidelines for diagnosis and therapy of MEN type 1 and type 2 ML Brandi, RF Gagel, A Angeli, JP Bilezikian, P Beck-Peccoz, C Bordi, ... The Journal of Clinical Endocrinology & Metabolism 86 (12), 5658-5671, 2001 | 2125 | 2001 |
| Phaeochromocytoma JWM Lenders, G Eisenhofer, M Mannelli, K Pacak The Lancet 366 (9486), 665-675, 2005 | 1508 | 2005 |
| Biochemical diagnosis of pheochromocytoma: which test is best? JWM Lenders, K Pacak, MCM Walther, WM Linehan, M Mannelli, ... Jama 287 (11), 1427-1434, 2002 | 1228 | 2002 |
| A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients GP Rossi, G Bernini, C Caliumi, G Desideri, B Fabris, C Ferri, C Ganzaroli, ... Journal of the American College of Cardiology 48 (11), 2293-2300, 2006 | 1168 | 2006 |
| Pheochromocytoma: recommendations for clinical practice from the First International Symposium K Pacak, G Eisenhofer, H Ahlman, SR Bornstein, AP Gimenez-Roqueplo, ... Nature Reviews Endocrinology 3 (2), 92, 2007 | 658 | 2007 |
| Adjuvant mitotane treatment for adrenocortical carcinoma M Terzolo, A Angeli, M Fassnacht, F Daffara, L Tauchmanova, PA Conton, ... New England Journal of Medicine 356 (23), 2372-2380, 2007 | 644 | 2007 |
| Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma I Comino-Méndez, FJ Gracia-Aznárez, F Schiavi, I Landa, ... Nature genetics 43 (7), 663, 2011 | 426 | 2011 |
| An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective … FH van Nederveen, J Gaal, J Favier, E Korpershoek, RA Oldenburg, ... The lancet oncology 10 (8), 764-771, 2009 | 402 | 2009 |
| Renal damage in primary aldosteronism: results of the PAPY Study GP Rossi, G Bernini, G Desideri, B Fabris, C Ferri, G Giacchetti, C Letizia, ... Hypertension 48 (2), 232-238, 2006 | 387 | 2006 |
| Integrated genomic characterization of adrenocortical carcinoma G Assié, E Letouzé, M Fassnacht, A Jouinot, W Luscap, O Barreau, ... Nature genetics 46 (6), 607, 2014 | 317 | 2014 |
| Pheochromocytomas in von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2 display distinct biochemical and clinical phenotypes G Eisenhofer, MM Walther, TT Huynh, ST Li, SR Bornstein, A Vortmeyer, ... The Journal of Clinical Endocrinology & Metabolism 86 (5), 1999-2008, 2001 | 296 | 2001 |
| The immune landscape of cancer V Thorsson, DL Gibbs, SD Brown, D Wolf, DS Bortone, THO Yang, ... Immunity 48 (4), 812-830. e14, 2018 | 267 | 2018 |
| The theory of constructed emotion: an active inference account of interoception and categorization LF Barrett Social cognitive and affective neuroscience 12 (1), 1-23, 2017 | 255 | 2017 |
| Pheochromocytoma in Italy: a multicentric retrospective study M Mannelli, L Ianni, A Cilotti, A Conti European Journal of Endocrinology 141 (6), 619-624, 1999 | 246 | 1999 |
| Clinically guided genetic screening in a large cohort of Italian patients with pheochromocytomas and/or functional or nonfunctional paragangliomas M Mannelli, M Castellano, F Schiavi, S Filetti, M Giacchè, L Mori, ... The Journal of Clinical Endocrinology & Metabolism 94 (5), 1541-1547, 2009 | 243 | 2009 |
| Comprehensive characterization of cancer driver genes and mutations MH Bailey, C Tokheim, E Porta-Pardo, S Sengupta, D Bertrand, ... Cell 173 (2), 371-385. e18, 2018 | 237 | 2018 |
| MAX mutations cause hereditary and sporadic pheochromocytoma and paraganglioma N Burnichon, A Cascón, F Schiavi, NP Morales, I Comino-Méndez, ... Clinical Cancer Research 18 (10), 2828-2837, 2012 | 231 | 2012 |
| Measurements of plasma methoxytyramine, normetanephrine, and metanephrine as discriminators of different hereditary forms of pheochromocytoma G Eisenhofer, JWM Lenders, H Timmers, M Mannelli, SK Grebe, ... Clinical chemistry 57 (3), 411-420, 2011 | 222 | 2011 |
| Angiotensin II stimulates the synthesis and secretion of vascular permeability factor/vascular endothelial growth factor in human mesangial cells C Pupilli, L Lasagni, P Romagnani, F BELLINI, M MANNELLI, ... Journal of the American Society of Nephrology 10 (2), 245-255, 1999 | 217 | 1999 |
| Plasma methoxytyramine: a novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumour size, location and SDHB mutation status G Eisenhofer, JWM Lenders, G Siegert, SR Bornstein, P Friberg, ... European journal of cancer 48 (11), 1739-1749, 2012 | 212 | 2012 |
